dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Dettorre, Gino M |
dc.contributor.author | Dolly, Saoirse |
dc.contributor.author | Loizidou, Angela |
dc.contributor.author | Chester, John |
dc.contributor.author | Jackson, Amanda |
dc.contributor.author | Mukherjee, Uma |
dc.contributor.author | Aguilar Company, Juan |
dc.contributor.author | Mirallas Viñas, Oriol |
dc.contributor.author | García Illescas, David |
dc.contributor.author | Ruiz Camps, Isabel |
dc.contributor.author | Tabernero Caturla, Josep |
dc.contributor.author | Saoudi Gonzalez, Nadia |
dc.date.accessioned | 2021-11-15T12:09:14Z |
dc.date.available | 2021-11-15T12:09:14Z |
dc.date.issued | 2021-03-22 |
dc.identifier.citation | Dettorre GM, Dolly S, Loizidou A, Chester J, Jackson A, Mukherjee U, et al. Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score. J Immunother Cancer. 2021 Mar 22;9(3):e002277. |
dc.identifier.issn | 2051-1426 |
dc.identifier.uri | https://hdl.handle.net/11351/6547 |
dc.description | Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Inflamació; Mediadors d'inflamació |
dc.description.sponsorship | This work was supported by grant funding from the Wellcome Trust Strategic Fund (PS3416 to DJP) and acknowledges infrastructural support by the Cancer Research UK Imperial Centre and the Imperial NIHR BRC. AG is supported by the AIRC IG (grant number 14230), Associazione Italiana per la Ricerca sul Cancro Foundation, Milan, Italy. |
dc.language.iso | eng |
dc.publisher | BMJ Publishing Group |
dc.relation.ispartofseries | Journal for ImmunoTherapy of Cancer;9(3) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | COVID-19 (Malaltia) - Complicacions |
dc.subject | Càncer - Epidemiologia |
dc.subject | Inflamació |
dc.subject.mesh | Systemic Inflammatory Response Syndrome |
dc.subject.mesh | Neoplasms |
dc.subject.mesh | Coronavirus Infections |
dc.subject.mesh | /complications |
dc.title | Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1136/jitc-2020-002277 |
dc.subject.decs | síndrome de respuesta inflamatoria sistémica |
dc.subject.decs | neoplasias |
dc.subject.decs | infecciones por Coronavirus |
dc.subject.decs | /complicaciones |
dc.relation.publishversion | http://dx.doi.org/10.1136/jitc-2020-002277 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Dettorre GM] Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK. [Dolly S] Medical Oncology, Guy’s and St Thomas’ NHS Foundation Trust (GSTT), London, UK. [Loizidou A] Department of Infectious Diseases, Internal Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. [Chester J] Medical Oncology, School of Medicine, Cardiff University, Cardiff, UK. Medical Oncology, Velindre Cancer Centre, Cardiff, UK. [Jackson A] Clinical Trials, Velindre Cancer Centre, Cardiff, UK. [Mukherjee U] Medical Oncology, Barts Health NHS Trust, London, UK. [Aguilar-Company J] Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei de Malalties Infeccioses, Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Mirallas O, Saoudi-Gonzalez N, García-Illescas D] Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Ruiz-Camps I] Servei de Malalties Infeccioses, Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Tabernero J] Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. IOB-Quiron, UVic-UCC, Barcelona, Spain |
dc.identifier.pmid | 33753569 |
dc.identifier.wos | 000631879100004 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |